Disease | hepatorenal syndrome |
Comorbidity | C0023890|cirrhosis |
Sentences | 18 |
PubMedID- 22971333 | Non-inclusion criteria were pregnancy, age of less than 18 years, known renal artery stenosis, known end-stage renal disease or chronic kidney disease defined by a glomerular filtration rate (gfr) of less than 30 ml/minute per 1.73 m2, angiotensin-converting enzyme inhibitor and non-steroidal anti-inflammatory treatment, cirrhosis with hepatorenal syndrome, and a major cardiogenic component in septic shock defined as a need for epinephrine or dobutamine or both. |
PubMedID- 25983746 | Treatment of hepatorenal syndrome (hrs) in patients with liver cirrhosis is still challenging and characterized by a very high mortality. |
PubMedID- 21285885 | Prevention of hepatorenal syndrome in patients with cirrhosis and ascites: a pilot randomized control trial between pentoxifylline and placebo. |
PubMedID- 19710033 | Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment. |
PubMedID- 19952764 | Objectives: renal failure is common in cirrhosis frequently due to hepatorenal syndrome (hrs). |
PubMedID- 22057374 | Cystatin c is a good predictor of hepatorenal syndrome and survival in patients with cirrhosis who have normal serum creatinine levels. |
PubMedID- 20581246 | Refractory ascites is a frequent complication of advanced cirrhosis and is associated with hepatorenal syndrome and hepatic hydrothorax. |
PubMedID- 21858100 | This overproduction of proinflammatory cytokines leads to various complications, such as spontaneous bacterial peritonitis (sbp) and hepatorenal syndrome (hrs) in patients with advanced cirrhosis [5], [6]. |
PubMedID- 24631577 | Nonselective beta blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis. |
PubMedID- 22094211 | hepatorenal syndrome occurs in patients with advanced liver cirrhosis and is associated with functional renal impairment and poor prognosis. |
PubMedID- 25903705 | Magnetic resonance elastography in the detection of hepatorenal syndrome in patients with cirrhosis and ascites. |
PubMedID- 24151614 | [20] showed that survival of pts with type 1 hepatorenal syndrome associated with cirrhosis varied with liver disease etiology. |
PubMedID- 21484118 | Aim: evaluation of the clinical significance of cystatin c as a predictor of hepatorenal syndrome (hrs) in patients with liver cirrhosis, ascites, and normal serum cr level. |
PubMedID- 24508549 | Type-1 hepatorenal syndrome in patients with cirrhosis and infection vs. |
PubMedID- 22637695 | Background: hepatorenal syndrome in cirrhosis with ascites is a well-defined entity with significant morbidity and mortality. |
PubMedID- 22811919 | cirrhosis patients with hepatorenal syndrome often need dialysis. |
PubMedID- 19837678 | Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. |
PubMedID- 22055590 | Serum cystatin c in advanced liver cirrhosis and different stages of the hepatorenal syndrome. |
Page: 1